Pacific Standard, October 8, 2015. Federal scrutiny has been a long time coming for Essure: Since the device was approved nearly 13 years ago, thousands of women have filed complaints reporting punctured tubes, debilitating muscle fatigue, and severe pain.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Pharmaceutical industry, under scrutiny for prices, has history of big political wins
Center for Responsive Politics, October 2, 2015. Soaring drug prices already had customers unhappy. The pharmaceutical industry hardly needed a new poster boy to add volume and passion to the complaints.
Read More »Pharmaceutical Industry, Under Scrutiny for Prices, Has History of Big Political Wins
Center for Responsive Politics, October 2, 2015. Soaring drug prices already had customers unhappy. The pharmaceutical industry hardly needed a new poster boy to add volume and passion to the complaints.
Read More »Investigation: Advisory Panel Suggests Limited Use of Popular Contraceptive Essure
WCBD NEWS 2, September 29, 2015. An advisory panel is now recommending limited use of the popular birth control Essure until more is known about its safety. The advisory panel suggests women with an allergy to metal, an autoimmune disease or history of pelvic inflammatory disease stay away from Essure right now.
Read More »The ‘Safe’ Birth Control That Wasn’t
The Daily Beast, September 24, 2014. After participating in clinical trials for Essure, a contraceptive implant, several women complained of severe pain and bleeding—but they say their trial records were altered.
Read More »